Cargando…
Glucocorticoid toxicity reduction with mepolizumab using the Glucocorticoid Toxicity Index
BACKGROUND: Reduction in glucocorticoid exposure is the primary benefit of new biologic treatments in severe asthma, but there is currently no evidence that reduction in glucocorticoid exposure corresponds to a proportionate reduction in associated toxicity. OBJECTIVES: To use the validated Glucocor...
Autores principales: | McDowell, P. Jane, Stone, John H., Zhang, Yuqing, Honeyford, Kirsty, Dunn, Louise, Logan, R. Jayne, McGarvey, Lorcan P.A., Butler, Claire A., Heaney, Liam G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770919/ https://www.ncbi.nlm.nih.gov/pubmed/34210787 http://dx.doi.org/10.1183/13993003.00160-2021 |
Ejemplares similares
-
The Role of Quantification of Glucocorticoid-associated Toxicity in Severe Asthma
por: McDowell, PJ, et al.
Publicado: (2021) -
Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: A cohort study
por: Liang, Yicong, et al.
Publicado: (2022) -
An observational study to determine the relationship between cough frequency and markers of inflammation in severe asthma
por: Holmes, Joshua, et al.
Publicado: (2022) -
Objective and Subjective Measurement of Cough in Asthma: A Systematic Review of the Literature
por: Holmes, Joshua, et al.
Publicado: (2022) -
Adverse perception of cough in patients with severe asthma: a discrete choice experiment
por: Holmes, Joshua, et al.
Publicado: (2023)